ENPNewswire-September 2, 2019--Protalix BioTherapeutics Receives Listing Deficiency Letter
from NYSE American
The Nasdaq deficiency letter
has no immediate effect on the listing of the Company's ADR, and its ADR will continue to trade on The Nasdaq Capital Market under the symbol "JRJC" at this time.
(NYSE American: DPW) a diversified holding company announced it has received a deficiency letter
(the "Letter") from NYSE American, LLC (the "Exchange") indicating that the company is not in compliance with the continued listing standards as set forth in Section 1003(f)(v) of the NYSE American company Guide (the "company Guide"), the company said.
DPW Holdings announced it had received a deficiency letter
from NYSE indicating that the company is not in compliance with the continued listing standards as set forth in Section 1003 of the NYSE American company guide.
International Resource News-January 14, 2019--EnSync receives deficiency letter
from NYSE American
(NYSE: IEC) said that it has received a deficiency letter
from the NYSE MKT LLC indicating that IEC has failed to file its quarterly report on Form 10-Q for the quarter ended December 26, 2014 by the requisite deadline of the Securities and Exchange Commission.
(Minneapolis MN), which makes medical products to treat urological disorders, said it received a deficiency letter
from the Nasdaq Global Market.
Riviera Holdings Corporation said it intends to voluntarily delist its common stock from NYSE Amex LLC following receipt of a deficiency letter
from the exchange indicating that the company is currently not in compliance with certain of the exchangeOs continued listing standards.
Pyramid had previously received a deficiency letter
from Nasdaq advising that, as a result of Scott Barnum's appointment as CEO and president, and his departure from the audit committee, Pyramid was not in compliance with rules that require a listed issuer to have at least three independent members on its audit committee.
If you're not in compliance with all of the procedures the SEC or your state agency (agencies often simply adopt and copy SEC regulations) requires, you will be issued something called a "deficiency letter
" and given a fixed period of time in which to bring your firm's procedures into compliance.
The examination has several possible outcomes: OCIE will notify the adviser that it found no violations, it will send the adviser a deficiency letter
outlining violations and requesting corrective action or refer the adviser to the SEC Division of Enforcement for further investigation.